HJY-ATRQβ-001

N/A

Report date: 2026/03/30 20:02:02

Base Information

Drug NameHJY-ATRQβ-001
Drug Alias NameHJY-ATRQβ-001HJYATRQβ001
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionAngiotensin II Receptor Type 1 modulators
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuhan Huajiyuan Biotechnology Dev Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesWuhan Huajiyuan Biotechnology Dev Co Ltd
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A